RILONACEPT REDUCES THE OCCURRENCE OF GOUT FLARES THAT MAY BE PRECIPITATED BY INITIATION OF URATE-LOWERING THERAPY

被引：0
|
作者：
Knapp, H. R. [1 ]
Schumacher, R. [2 ]
Sundy, J. S. [3 ]
Terkeltauab, R. [4 ]
Mellis, S. [5 ]
King-Davis, S. [5 ]
Wu, R. [5 ]
Weinstein, S. [5 ]
Radin, A. [1 ,5 ]
机构：
[1] Billings Clin Res Ctr, Billings, MT USA
[2] Univ Penn, VAMC, Philadelphia, PA 19104 USA
[3] Duke Univ, Durham, NC USA
[4] Univ Calif San Diego, La Jolla, CA 92093 USA
[5] Regeneron Pharmaceut Inc, Tarrytown, NY 10591 USA
来源：
JOURNAL OF GENERAL INTERNAL MEDICINE | 2009年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R19 [保健组织与事业（卫生事业管理）];
学科分类号：
摘要：
引用
收藏
页码：164 / 164
页数：1
相关论文
共 50 条
  • [31] Factors influencing the response to urate-lowering therapy in patients with gout
    Cai, F.
    Rui, W.
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 1308 - 1308
  • [32] Improving adherence to urate-lowering therapy in people living with gout
    Coleshill, Matthew J.
    Aung, Eindra
    Nguyen, Amy D.
    Stocker, Sophie L.
    Baysari, Melissa T.
    Kamel, Bishoy
    Schulz, Marcel
    McLachlan, Andrew J.
    Day, Richard O.
    [J]. INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2019, 22 (04) : 542 - 544
  • [33] Rilonacept (interleukin-1 trap) in the prevention of acute gout flares during initiation of urate-lowering therapy: Results of a phase II randomized, double-blind, placebo-controlled trial
    Schumacher, H. Ralph, Jr.
    Sundy, John S.
    Terkeltaub, Robert
    Knapp, Howard R.
    Mellis, Scott J.
    Stahl, Neil
    Yancopoulos, George D.
    Soo, Yuhwen
    King-Davis, Shirletta
    Weinstein, Steven P.
    Radin, Allen R.
    [J]. ARTHRITIS AND RHEUMATISM, 2012, 64 (03): : 876 - 884
  • [34] Implementing treat-to-target urate-lowering therapy during hospitalisations for gout flares: a prospective cohort study
    Russell, Mark D.
    Ameyaw-Kyeremeh, Louise
    Dell Accio, Flora
    Lapham, Heather
    Head, Natalie
    Stovin, Christopher
    Patel, Vishit
    Clarke, Benjamin
    Nagra, Deepak
    Alveyn, Edward
    Adas, Maryam A.
    Bechman, Katie
    de la Puente, Maria A.
    Ellis, Benjamin
    Byrne, Corrine
    Patel, Rina
    Rutherford, Andrew, I
    Cantle, Fleur
    Norton, Sam
    Roddy, Edward
    Hudson, Joanna
    Cope, Andrew P.
    Galloway, James B.
    [J]. RHEUMATOLOGY, 2024, 63
  • [35] Adherence with urate-lowering therapies for the treatment of gout
    Leslie R Harrold
    Susan E Andrade
    Becky A Briesacher
    Marsha A Raebel
    Hassan Fouayzi
    Robert A Yood
    Ira S Ockene
    [J]. Arthritis Research & Therapy, 11
  • [36] Adherence with urate-lowering therapies for the treatment of gout
    Harrold, Leslie R.
    Andrade, Susan E.
    Briesacher, Becky A.
    Raebel, Marsha A.
    Fouayzi, Hassan
    Yood, Robert A.
    Ockene, Ira S.
    [J]. ARTHRITIS RESEARCH & THERAPY, 2009, 11 (02)
  • [37] Rebranding Gout: Could a Name Change for Gout Improve Adherence to Urate-Lowering Therapy?
    Coleshill, Matthew J.
    Aung, Eindra
    Carland, Jane E.
    Faasse, Kate
    Stocker, Sophie
    Day, Richard O.
    [J]. THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2021, 55 (01) : 138 - 141
  • [38] Rebranding Gout: Could a Name Change for Gout Improve Adherence to Urate-Lowering Therapy?
    Matthew J. Coleshill
    Eindra Aung
    Jane E. Carland
    Kate Faasse
    Sophie Stocker
    Richard O. Day
    [J]. Therapeutic Innovation & Regulatory Science, 2021, 55 : 138 - 141
  • [39] Urate-lowering Therapy and Chronic Kidney Disease Development in Patients with Gout
    Yen, Fu-Shun
    Wei, James Cheng-Chung
    Chang, Chia-Ling
    Yang, Chen-Chang
    Hsu, Chih-Cheng
    Hwu, Chii-Min
    [J]. INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2021, 18 (12): : 2599 - 2606
  • [40] Letter to the editor regarding "urate-lowering therapy for patients with gout on hemodialysis"
    Tsai, Yung-Shun
    Lee, Yung-Heng
    Ko, Meng-Yu
    [J]. INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2023, 26 (01) : 177 - 178
12345